Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa
BelgiumStudy of ruxolitinib cream for treating hidradenitis suppurativa in adult patients
BulgariaStudy of Bimekizumab for Children and Adolescents with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
CroatiaStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
BelgiumStudy on the Effects of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria
BulgariaStudy on the Effects and Safety of Piclidenoson for Patients with Moderate-to-Severe Plaque Psoriasis
BulgariaStudy on the Safety of a New Chickenpox Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months
BulgariaStudy on the Effectiveness of Skin Patch Vaccination with Measles, Mumps, and Rubella Vaccine in Healthy Volunteers
DenmarkStudy of HSV immunotherapy (HSVTI) for healthy adults aged 18-40 and people with recurrent genital herpes aged 18-60
BelgiumStudy on How Bimekizumab Affects People with Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
GermanyStudy on Etrasimod Arginine for Patients with Ulcerative Colitis, Alopecia Areata, Atopic Dermatitis, and Eosinophilic Esophagitis
BelgiumThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
